CLSA’s VP of Federal Government Relations Jenny Carey was recently featured in MD+DI commenting on life sciences priorities leading into the 2018 midterm elections
CLSA’s 2018 Pantheon DiNA Awards are coming up 11/30. Learn about the individuals & companies being honored in this BioSpace article.
CLSA was recently featured in Politico applauding Gov. Jerry Brown on signing SB 1121 into law, to protect clinical trials and patient research in California.
CLSA’s 2018 California Life Sciences Industry Report was recently cited in GEN News to help capture the top 10 U.S. Biopharma hubs.
CLSA recently spoke with STAT News regarding SB 1121, critical legislation on Gov. Brown’s desk that will preserve California patient access to clinical trials and allow innovative research to continue.
Did you miss CLSA’s Evening With Thought Leaders event in August? Check out this article from the San Diego Business Journal to learn more about the digital health symposium.
CLSA President & CEO Sara Radcliffe was recently quoted in the San Francisco Business Times commenting on a new report that shows California’s life sciences sector has the most biotech R&D jobs in the nation.
Read recent media coverage of CLSA in InsideHealthPolicy.
California’s new Consumer Privacy Act (AB 375), the toughest data privacy law in the nation, will impose stringent new requirements on the state’s high-profile tech companies in 2020. Its impacts on the life sciences industry, though, remain unclear. CLSA’s State Government Relations team sat down with BioWorld to discuss what the measure means for innovative biomedical companies.
CLSA recently sat down with the San Diego Business Journal to discuss the path forward for medical device tax repeal legislation in the U.S. Senate.